You are here: Industry Insights > COVID-19

News List

Heritage Christian Services Launches COVID-19 Screening and Tracking Hotline to Help Stem the Spread of the Coronavirus prnewswire
April 16, 2020
Heritage Christian Services has launched a COVID-19 hotline for employees and those who use its services to report symptoms and get help.
A dive into COVID-19 treatment avenues expresspharma
April 16, 2020
“Frost & Sullivan’s analysis reveals that hydroxychloroquine and Remdesivir are likely to emerge as important treatment strategies for COVID-19,” ...
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19 expresspharma
April 16, 2020
India has agreed to sell hydroxychloroquine (HCQ) tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters recently, with New Delhi partially lifting its bar on exports of the anti-malarial drug.
Ridgeback Biotherapeutics announces MHRA clearance to begin human testing of EIDD-2801 in UK for COVID-19 pharmaceutical-business-review
April 16, 2020
Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Hope Biosciences gets FDA nod for phase 2 COVID-19 stem cell therapy trial pharmaceutical-business-review
April 16, 2020
Hope Biosciences has been given clearance from the US Food and Drug Administration (FDA) to move ahead with a phase 2 trial to evaluate its investigational stem cell therapy in providing immune support against COVID-19.
AstraZeneca Initiates Calquence Clinical Trial against COVID-19 americanpharmaceuticalreview
April 16, 2020
AstraZeneca will initiate a randomized, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm) associated with COVID-19 infection in severely ill patients.
Xylyx Bio Offers Advanced Lung Models to Accelerate COVID-19-Related Drug Development americanpharmaceuticalreview
April 16, 2020
Xylyx Bio announced availability of products that recreate the lung environment in vitro to provide a predictive model.
BD Announces Second FDA Emergency Use Authorization, CE Mark for COVID-19 Molecular Diagnostic americanpharmaceuticalreview
April 16, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19.
FDA grants emergency use authorisation to blood purification system for COVID-19 europeanpharmaceuticalreview
April 16, 2020
A blood purification system to reduce cytokine storms in COVID-19 patients has been given emergency use authorisation by the FDA.
NantKwest and ImmunityBio work on Covid-19 vaccines and drugs pharmaceutical-technology
April 16, 2020
NantKwest and its sister firm ImmunityBio have partnered for the development of potential vaccines and therapeutics against Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page